Publications by authors named "Donald C Moore"

31Publications

Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients.

Authors:
Anna Lee Chris Larck Donald C Moore

J Oncol Pharm Pract 2020 Dec 26:1078155220982648. Epub 2020 Dec 26.

Department of Pharmacy, Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
December 2020

Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center.

Authors:
Donald C Moore Tsion Gebru Dragos Plesca

J Oncol Pharm Pract 2020 Dec 9:1078155220977898. Epub 2020 Dec 9.

Levine Cancer Institute, Charlotte, NC, USA.

View Article and Find Full Text PDF
December 2020

Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.

Authors:
Kristyn Y DiSogra Thuy Tran Justin R Arnall Amanda Janes Donald C Moore Steven I Park

J Oncol Pharm Pract 2020 Oct 27:1078155220967440. Epub 2020 Oct 27.

Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
October 2020

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma.

Authors:
Donald C Moore Viera Nelson Alaa Muslimani

Ann Hematol 2020 Oct 1. Epub 2020 Oct 1.

Department of Hematology/Oncology, Atrium Health, Levine Cancer Institute, 1656 Riverchase Blvd, Rock Hill, SC, 29732, USA.

View Article and Find Full Text PDF
October 2020

Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab.

Authors:
Donald C Moore Justin R Arnall Daniel L Thompson Allison L Martin Jordan Robinson Ami Ndiaye Barry Paul Shebli Atrash Manisha Bhutani Peter M Voorhees Saad Z Usmani

Clin Lymphoma Myeloma Leuk 2020 Oct 7;20(10):e777-e781. Epub 2020 Jun 7.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute, Charlotte, NC.

View Article and Find Full Text PDF
October 2020

Caplacizumab: an anti-von Willebrand factor antibody for the treatment of thrombotic thrombocytopenic purpura.

Authors:
Alyssa L Hollifield Justin R Arnall Donald C Moore

Am J Health Syst Pharm 2020 07;77(15):1201-1207

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Concord, NC.

View Article and Find Full Text PDF
July 2020

Dialysis Independence Following Combination Daratumumab, Thalidomide, Bortezomib, Cyclophosphamide, and Dexamethasone in Multiple Myeloma With Severe Renal Failure.

Authors:
Donald C Moore Justin R Arnall Amanda Janes Mauricio Pineda-Roman

Clin Lymphoma Myeloma Leuk 2020 Jul 7;20(7):e395-e398. Epub 2020 Apr 7.

Levine Cancer Institute, Concord, NC.

View Article and Find Full Text PDF
July 2020

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis.

Authors:
Amani M Cobert Catherine Helms Chris Larck Donald C Moore

Ther Adv Drug Saf 2020 21;11:2042098620915058. Epub 2020 Apr 21.

Pharmacist Clinical Coordinator, Hematology/Oncology, Atrium Health, Levine Cancer Institute, 100 Medical Park Drive, Concord, NC 28025, USA.

View Article and Find Full Text PDF
April 2020

Impact of Body Mass Index on the Incidence of Bortezomib-induced Peripheral Neuropathy in Patients With Newly Diagnosed Multiple Myeloma.

Authors:
Donald C Moore J Tanner Ringley David Nix Ala'a Muslimani

Clin Lymphoma Myeloma Leuk 2020 03 18;20(3):168-173. Epub 2019 Sep 18.

Atrium Health, Levine Cancer Institute, Rock Hill, SC. Electronic address:

View Article and Find Full Text PDF
March 2020

Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience.

Authors:
Thuy Tran Justin Arnall Donald C Moore Leslie Ward Surabhi Palkimas Louise Man

J Thromb Thrombolysis 2020 Apr;49(3):431-440

Division of Hematology/Oncology, University of Virginia Health System, PO Box 800716, Charlottesville, VA, 22908, USA.

View Article and Find Full Text PDF
April 2020

Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.

Authors:
Donald C Moore Joseph B Elmes Priscila A Shibu Chris Larck Steven I Park

Ann Pharmacother 2020 04 25;54(4):371-379. Epub 2019 Oct 25.

Atrium Health, Levine Cancer Institute, Concord, NC, USA.

View Article and Find Full Text PDF
April 2020

Eltrombopag-Associated Acneiform Rash: A Case Report.

Authors:
Amani M Cobert James G Wall Donald C Moore

Am J Ther 2019 Sep 17. Epub 2019 Sep 17.

Atrium Health, Levine Cancer Institute, Concord, NC.

View Article and Find Full Text PDF
September 2019

Fostamatinib for the treatment of immune thrombocytopenia in adults.

Authors:
Donald C Moore Tsion Gebru Alaa Muslimani

Am J Health Syst Pharm 2019 May;76(11):789-794

Department of Hematology/Oncology, Atrium Health, Levine Cancer Institute, Rock Hill, SC.

View Article and Find Full Text PDF
May 2019

Neutropenia-Associated Outcomes in Patients With Breast Cancer Receiving Myelosuppressive Chemotherapy With Reduced Doses of Pegfilgrastim.

Authors:
Donald C Moore Tsion Gebru Annie Pellegrino Adenike Fasan Jolly Patel J Tanner Ringley

J Pharm Pract 2020 Dec 27;33(6):779-783. Epub 2019 Mar 27.

Department of Pharmacy, Atrium Health, Levine Cancer Institute, Charlotte, NC, USA.

View Article and Find Full Text PDF
December 2020

Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.

Authors:
Justin R Arnall Donald C Moore Hailey L Hill Sarah Griffin Maxine K Mueller Lesli A Lavery Peter M Voorhees Saad Z Usmani

Leuk Lymphoma 2019 09 8;60(9):2295-2298. Epub 2019 Mar 8.

Department of Hematologic Oncology and Blood Disorders, Atrium Health, Levine Cancer Institute , Charlotte , NC , USA.

View Article and Find Full Text PDF
September 2019

Olaratumab: A New Strategy in the Treatment of Advanced Soft-Tissue Sarcoma.

Authors:
Donald C Moore Lesli A Lavery

J Adv Pract Oncol 2018 Mar 1;9(2):235-240. Epub 2018 Mar 1.

Levine Cancer Institute, Atrium Health, Rock Hill, South Carolina; and Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.

View Article and Find Full Text PDF
March 2018

Case series of docetaxel-induced dorsal hand-foot syndrome.

Authors:
Jolly Patel J Tanner Ringley Donald C Moore

Ther Adv Drug Saf 2018 Aug 21;9(8):495-498. Epub 2018 May 21.

Pharmacist Clinical Coordinator - Oncology, Levine Cancer Institute, Atrium Health, Department of Pharmacy, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.

View Article and Find Full Text PDF
August 2018

Poly (ADP-ribose) Polymerase Inhibitors in the Management of Ovarian Cancer: A Drug Class Review.

Authors:
J Tanner Ringley Donald C Moore Jolly Patel Maegan S Rose

P T 2018 Sep;43(9):549-556

View Article and Find Full Text PDF
September 2018

Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.

Authors:
Donald C Moore Justin R Arnall Dragos C Plesca

Am J Health Syst Pharm 2018 Nov 21;75(22):1824-1830. Epub 2018 Aug 21.

Department of Pharmacy, Levine Cancer Institute, Atrium Health, Charlotte, NC.

View Article and Find Full Text PDF
November 2018

Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma.

Authors:
Donald C Moore Justin R Arnall R Donald Harvey

J Oncol Pharm Pract 2019 Apr 31;25(3):613-622. Epub 2018 Jul 31.

2 Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article and Find Full Text PDF
April 2019

Metastatic Soft Tissue Sarcomas: A Review Of Treatment and New Pharmacotherapies.

Authors:
Eric K Singhi Donald C Moore Alaa Muslimani

P T 2018 Jul;43(7):410-429

View Article and Find Full Text PDF
July 2018

Rhabdomyolysis With Abiraterone Exposure: A Brief Review of the Food and Drug Administration Adverse Event Reporting System (FAERS).

Authors:
Donald C Moore J Tanner Ringley

Ann Pharmacother 2018 11 17;52(11):1160-1161. Epub 2018 Jun 17.

View Article and Find Full Text PDF
November 2018

Case Report of Ipilimumab-Induced Diffuse, Nonnecrotizing Granulomatous Lymphadenitis and Granulomatous Vasculitis.

Authors:
Kari Arellano James C Mosley Donald C Moore

J Pharm Pract 2018 Apr 21;31(2):227-229. Epub 2017 Mar 21.

3 Department of Pharmacy, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
April 2018

Rucaparib: A Poly(ADP-Ribose) Polymerase Inhibitor for BRCA-Mutated Relapsed Ovarian Cancer.

Authors:
Donald C Moore J Tanner Ringley Jolly Patel

J Pharm Pract 2019 Apr 22;32(2):219-224. Epub 2017 Nov 22.

1 Department of Pharmacy, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
April 2019

Nilotinib-Induced Ocular Toxicity: A Case Report.

Authors:
Donald C Moore Alaa Muslimani Pamela Sinclair

Am J Ther 2018 Sep/Oct;25(5):e570-e571

Oncology, Levine Cancer Institute, Carolinas HealthCare System, Rock Hill, SC.

View Article and Find Full Text PDF
March 2019

Acneiform Rash With Ramucirumab and Paclitaxel in a Patient With Recurrent Esophageal Cancer.

Authors:
Donald C Moore

Am J Ther 2018 Sep/Oct;25(5):e557-e558

Department of Pharmacy, Carolinas HealthCare System, Levine Cancer Institute, Rock Hill, SC.

View Article and Find Full Text PDF
March 2019

Pegfilgrastim-Induced Bone Pain: A Review on Incidence, Risk Factors, and Evidence-Based Management.

Authors:
Donald C Moore Annie E Pellegrino

Ann Pharmacother 2017 Sep 19;51(9):797-803. Epub 2017 Apr 19.

1 Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article and Find Full Text PDF
September 2017

Drug-Induced Neutropenia: A Focus on Rituximab-Induced Late-Onset Neutropenia.

Authors:
Donald C Moore

P T 2016 Dec;41(12):765-768

View Article and Find Full Text PDF
December 2016

Necitumumab for the treatment of squamous cell non-small cell lung cancer.

Authors:
Jessica K Brinkmeyer Donald C Moore

J Oncol Pharm Pract 2018 Jan 2;24(1):37-41. Epub 2016 Dec 2.

2 Department of Pharmacy, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC 28204, USA.

View Article and Find Full Text PDF
January 2018

Cost savings analysis and toxicity audit of a bevacizumab dose rounding policy at a community cancer center.

Authors:
Donald C Moore Gary Neal McVey

J Oncol Pharm Pract 2018 Jan 19;24(1):42-46. Epub 2016 Oct 19.

2 Regional Director of Pharmacy, Southeast Health, Department of Pharmacy, Dexter, MO USA.

View Article and Find Full Text PDF
January 2018

Abiraterone-induced rhabdomyolysis: A case report.

Authors:
Donald C Moore Andrew Moore

J Oncol Pharm Pract 2017 Mar 9;23(2):148-151. Epub 2016 Jul 9.

Southeast Missouri Hospital, Cape Girardeau, MO, USA.

View Article and Find Full Text PDF
March 2017